Target intelligence / Profile preview

Heat shock protein family A member 13 (HSPA13)

Target
HSPA13
Molecular classification
Chaperone protein, ATPase, Heat shock protein (HSP70 family), Other
01

Overview

Heat shock protein family A member 13 (HSPA13) is a human protein encoded by the *HSPA13* gene and is a member of the HSP70 family, though it differs from canonical HSP70s by lacking a substrate-binding domain[2][4]. HSPA13 localizes to the endoplasmic reticulum (ER) and the ER membrane and plays a central role in the regulation of protein import through the ER translocon complex (including Sec61 and associated factors), assisting the proper folding, processing, and quality control of cytosolic and secretory proteins[4]. It possesses peptide-independent ATPase activity and is a stress-inducible gene regulated by the unfolded protein response[2][4]. HSPA13 promotes ER and cytoplasmic proteostasis, and its aberrant expression is implicated in several cancers—where it promotes proliferation, migration, and invasion (notably in hepatocellular carcinoma)—by stabilizing regulatory proteins such as TANK and modulating their degradation via the ubiquitin–proteasome pathway[1]. HSPA13 has also been implicated in plasma cell differentiation, ER stress response, and protein folding diseases such as prion disorders[1][4]. No specific drugs currently target HSPA13 directly, and mechanisms of drug action or therapeutic safety profiles have not been well-established. Its emerging roles in both oncogenesis and proteostasis present potential therapeutic opportunities and challenges.

Other names
Heat shock 70 kDa protein 13STCHMicrosomal stress-70 protein ATPase coreStress-70 protein chaperone microsome-associated 60 kDa proteinTestis secretory sperm-binding protein Li 199a
02

Biological functions

Protein foldingProteostasis (protein homeostasis)Protein import into the endoplasmic reticulumSecretory protein biogenesisUbiquitin–proteasome pathway regulationInhibition of apoptosisER-associated degradation
03

Disease associations

Cancer (especially hepatocellular carcinoma, gastric cancer, colon cancer, oral cancer)Protein misfolding diseasesPrion diseasesOther
04

Safety considerations

Targeting HSPA13 may disrupt proteostasis and ER/cytoplasmic protein homeostasis with possible widespread cytotoxicity[4]
05

Biomarkers

Overexpression is a prognostic marker of poor outcome in hepatocellular carcinoma[1]elevated in some cancers[1]

Beyond the preview

Go deeper on Heat shock protein family A member 13 (HSPA13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein family A member 13 (HSPA13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call